ProPhase Labs to Present at the H.C. Wainwright Bioconnect 2022 Virtual Conference
January 05, 2022 08:30 ET
|
ProPhase Labs, Inc.
GARDEN CITY, NY, Jan. 05, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (Nasdaq: PRPH), a diversified biotech and genomics company, announces today that Chairman and CEO Ted Karkus will present a...
ObsEva to Present at the H.C. Wainwright BioConnect 2022 Conference
January 03, 2022 07:00 ET
|
ObsEva SA
GENEVA, Switzerland January 3, 2022 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health, today...
ObsEva to Present at the H.C. Wainwright BioConnect 2022 Conference
January 03, 2022 01:00 ET
|
ObsEva SA
GENEVA, Switzerland January 3, 2022 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health, today...